×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Shooting date : 2022-03-11
Last update : 2022-07-20

Nouveautés et référentiels dans la prise en charge du cancer du sein

NOUVEAUTÉS ET RÉFÉRENTIELS DANS LA PRISE EN CHARGE DU CANCER DU SEIN Le saviez-vous ? 54.000 nouveaux cas de cancer du sein sont diagnostiqués chaque année ...

Share

Suggestions

Thursday, October 13th 2022 from 06pm to 07pm (GMT+1)
Honolulu : Thursday, October 13th 2022 from 07am to 08am (GMT-10)
San Francisco : Thursday, October 13th 2022 from 10am to 11am (GMT-7)
New York : Thursday, October 13th 2022 from 01pm to 02pm (GMT-4)
Buenos Aires : Thursday, October 13th 2022 from 02pm to 03pm (GMT-3)
Reykjavik : Thursday, October 13th 2022 from 05pm to 06pm (GMT)
London / Dublin : Thursday, October 13th 2022 from 06pm to 07pm (GMT+1)
Paris / Berlin : Thursday, October 13th 2022 from 07pm to 08pm (GMT+2)
Istanbul : Thursday, October 13th 2022 from 08pm to 09pm (GMT+3)
Moscou / Dubaï : Thursday, October 13th 2022 from 09pm to 10pm (GMT+4)
Bangkok : Friday, October 14th 2022 from 12am to 01am (GMT+7)
Shanghai : Friday, October 14th 2022 from 01am to 02am (GMT+8)
Tokyo : Friday, October 14th 2022 from 02am to 03am (GMT+9)
Sydney : Friday, October 14th 2022 from 04am to 05am (GMT+11)
Wellington : Friday, October 14th 2022 from 06am to 07am (GMT+13)

Les inhibiteurs de tyrosine kinase (TKI) et les anticorps conjugués (ADC) dans le cancer du sein mÃ...

Les nouveaux traitements, entre choix et complémentarité

Share

Session - 2

NOUVEAUTÉS ET RÉFÉRENTIELS DANS LA PRISE EN CHARGE DU CANCER DU SEIN

Share

Session - 3

NOUVEAUTÉS ET RÉFÉRENTIELS DANS LA PRISE EN CHARGE DU CANCER DU SEIN

Share

Session - 4

NOUVEAUTÉS ET RÉFÉRENTIELS DANS LA PRISE EN CHARGE DU CANCER DU SEIN

Share
Scroll Up